Medidata is conducting an ongoing study to better understand the regulatory positions, adoption, and variability regarding eConsent globally. The benefits of eConsent have been well documented, yet there is still concern and uncertainty around regulatory positions. This white paper is the first in a series to provide an overview of findings from the eConsent study, which includes the most recent feedback and guidance from relevant regulatory bodies.